GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Komipharm International Co Ltd (XKRX:041960) » Definitions » Cyclically Adjusted Price-to-FCF

Komipharm International Co (XKRX:041960) Cyclically Adjusted Price-to-FCF : (As of Jul. 23, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Komipharm International Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Komipharm International Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Komipharm International Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Komipharm International Co Cyclically Adjusted Price-to-FCF Chart

Komipharm International Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Komipharm International Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Komipharm International Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Komipharm International Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Komipharm International Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Komipharm International Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Komipharm International Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Komipharm International Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Komipharm International Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Komipharm International Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-17.515/122.5900*122.5900
=-17.515

Current CPI (Mar. 2025) = 122.5900.

Komipharm International Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -55.504 100.051 -68.008
201509 -65.524 100.111 -80.237
201512 -69.713 100.220 -85.273
201603 -54.243 100.561 -66.126
201606 -82.041 100.791 -99.785
201609 -22.237 101.461 -26.868
201612 2.967 101.561 3.581
201703 -46.305 102.851 -55.192
201706 -4.329 102.611 -5.172
201709 -18.937 103.491 -22.432
201712 -1.645 102.991 -1.958
201803 -71.757 104.101 -84.502
201806 -3.511 104.130 -4.133
201809 -44.275 105.651 -51.374
201812 -4.985 104.351 -5.856
201903 -21.602 104.491 -25.344
201906 -25.164 104.881 -29.413
201909 -47.869 105.200 -55.782
201912 7.333 105.121 8.552
202003 -28.950 105.354 -33.686
202006 26.810 105.112 31.268
202009 -36.132 106.198 -41.709
202012 -0.551 105.765 -0.639
202103 -8.572 107.357 -9.788
202106 23.710 107.579 27.018
202109 -28.914 108.759 -32.591
202112 -20.008 109.676 -22.364
202203 -37.070 111.848 -40.630
202206 11.000 114.072 11.821
202209 -19.323 114.715 -20.649
202212 4.816 115.179 5.126
202303 -28.696 116.507 -30.194
202306 36.114 117.182 37.781
202309 -26.015 118.964 -26.808
202312 -33.230 118.837 -34.279
202403 -5.250 120.123 -5.358
202406 22.090 120.007 22.565
202409 23.974 120.861 24.317
202412 29.257 121.135 29.608
202503 -17.515 122.590 -17.515

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Komipharm International Co  (XKRX:041960) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Komipharm International Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Komipharm International Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Komipharm International Co Business Description

Traded in Other Exchanges
N/A
Address
1236-6 Jungwang-Dong, Sihung, Gyeonggi, KOR, 429-450
Komipharm International Co Ltd is involved in the healthcare sector based in Korea. Its core business includes development and manufacture of veterinary vaccines and veterinary pharmaceuticals. The company produces its products under two divisions: veterinary vaccines such as total vaccines of respiratory disease for swine, vaccines of anthrax disease and black leg for cattle. The other division is made up of veterinary pharmaceuticals such as antibiotics, nutrients, disinfectants and others, which are used to treat pneumonia, pasteurellosis, enteritis, mastitis and swine erysipelas.

Komipharm International Co Headlines

No Headlines